Determining Optimal Therapy — Randomized Trials in Individual Patients
- 3 April 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 314 (14), 889-892
- https://doi.org/10.1056/nejm198604033141406
Abstract
Although the treatment of an individual patient in routine clinical practice has been likened to an experiment, the method is so susceptible to bias that we have come to demand multi-patient, double-blind, randomized controlled trials on matters of efficacy. Unfortunately, such trials have not or cannot be carried out for many clinical disorders; even when they have been executed their results may be difficult to extrapolate to individual patients.Keywords
This publication has 9 references indexed in Scilit:
- Methodologic problems in clinical trials in heart failureJournal of Chronic Diseases, 1985
- Crossover and Self-Controlled Designs in Clinical ResearchNew England Journal of Medicine, 1984
- Statistics and Single Case AnalysisPublished by Elsevier ,1984
- The Lie That Heals: The Ethics of Giving PlacebosAnnals of Internal Medicine, 1982
- Heart Failure in OutpatientsNew England Journal of Medicine, 1982
- Effect of theophylline on gastroesophageal reflux in normal adultsJournal of Allergy and Clinical Immunology, 1981
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979
- Bias in analytic researchJournal of Chronic Diseases, 1979
- Clinical biostatisticsClinical Pharmacology & Therapeutics, 1970